Slayton WB - Search Results

1

Establishing Cost-Effective Allocation of Proton Therapy for Patients With Mediastinal Hodgkin Lymphoma.

Mailhot Vega RB, Mohammadi H, Patel SI, Holtzman AL, Lockney NA, Lynch JW, Bansal MM, Liang X, Slayton WB, Parsons SK, Hoppe BS, Mendenhall NP. Mailhot Vega RB, et al. Among authors: slayton wb. Int J Radiat Oncol Biol Phys. 2022 Jan 1;112(1):158-166. doi: 10.1016/j.ijrobp.2021.07.1711. Epub 2021 Aug 2. Int J Radiat Oncol Biol Phys. 2022. PMID: 34348176

2

Improving the therapeutic ratio in Hodgkin lymphoma through the use of proton therapy.

Hoppe BS, Flampouri S, Lynch J, Slayton W, Zaiden R, Li Z, Mendenhall NP. Hoppe BS, et al. Oncology (Williston Park). 2012 May;26(5):456-9, 462-5. Oncology (Williston Park). 2012. PMID: 22730602 Free article. Review.

3

Involved-node proton therapy in combined modality therapy for Hodgkin lymphoma: results of a phase 2 study.

Hoppe BS, Flampouri S, Zaiden R, Slayton W, Sandler E, Ozdemir S, Dang NH, Lynch JW, Li Z, Morris CG, Mendenhall NP. Hoppe BS, et al. Int J Radiat Oncol Biol Phys. 2014 Aug 1;89(5):1053-1059. doi: 10.1016/j.ijrobp.2014.04.029. Epub 2014 Jun 10. Int J Radiat Oncol Biol Phys. 2014. PMID: 24928256 Free article. Clinical Trial.

4

Proton therapy to the subdiaphragmatic region in the management of patients with Hodgkin lymphoma.

Sachsman S, Hoppe BS, Mendenhall NP, Holtzman A, Li Z, Slayton W, Joyce M, Sandler E, Flampouri S. Sachsman S, et al. Leuk Lymphoma. 2015 Jul;56(7):2019-24. doi: 10.3109/10428194.2014.975802. Epub 2014 Nov 19. Leuk Lymphoma. 2015. PMID: 25315071

5

Proton Therapy for Pediatric Hodgkin Lymphoma.

Wray J, Flampouri S, Slayton W, Joyce M, Sandler E, Morris CG, Li Z, Indelicato DJ, Mendenhall NP, Hoppe BS. Wray J, et al. Pediatr Blood Cancer. 2016 Sep;63(9):1522-6. doi: 10.1002/pbc.26044. Epub 2016 May 3. Pediatr Blood Cancer. 2016. PMID: 27149120

6

Importance of baseline PET/CT imaging on radiation field design and relapse rates in patients with Hodgkin lymphoma.

Figura N, Flampouri S, Mendenhall NP, Morris CG, McCook B, Ozdemir S, Slayton W, Sandler E, Hoppe BS. Figura N, et al. Adv Radiat Oncol. 2017 Jan 18;2(2):197-203. doi: 10.1016/j.adro.2017.01.006. eCollection 2017 Apr-Jun. Adv Radiat Oncol. 2017. PMID: 28740932 Free PMC article.

7

Irradiating Residual Disease to 30 Gy with Proton Therapy in Pediatric Mediastinal Hodgkin Lymphoma.

Hoppe BS, Mailhot Vega RB, Mendenhall NP, Sandler ES, Slayton WB, Katzenstein H, Joyce MJ, Li Z, Flampouri S. Hoppe BS, et al. Among authors: slayton wb. Int J Part Ther. 2020 Spring;6(4):11-16. doi: 10.14338/IJPT-19-00077.1. Epub 2020 Apr 27. Int J Part Ther. 2020. PMID: 32582815 Free PMC article.

8

How we approach Philadelphia chromosome-positive acute lymphoblastic leukemia in children and young adults.

Slayton WB, Schultz KR, Silverman LB, Hunger SP. Slayton WB, et al. Pediatr Blood Cancer. 2020 Oct;67(10):e28543. doi: 10.1002/pbc.28543. Epub 2020 Aug 11. Pediatr Blood Cancer. 2020. PMID: 32779849

9

Integrin VLA-5 and FAK are Good Targets to Improve Treatment Response in the Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia.

Hu Z, Slayton WB. Hu Z, et al. Among authors: slayton wb. Front Oncol. 2014 May 15;4:112. doi: 10.3389/fonc.2014.00112. eCollection 2014. Front Oncol. 2014. PMID: 24860788 Free PMC article.

10

Minimal Change Disease as Initial Presentation of ALK-Positive Anaplastic Large-Cell Lymphoma in a Pediatric Patient.

Diaz K, Slayton W, Gupta N. Diaz K, et al. Case Rep Oncol. 2017 Nov 6;10(3):964-972. doi: 10.1159/000481851. eCollection 2017 Sep-Dec. Case Rep Oncol. 2017. PMID: 29279700 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

74 results

Search Page